This overexpression, potentially indicative of an efficacious anti-neoplastic immune response, ultimately precipitates the functional exhaustion of tumor-specific CD8+ T-cells, as indicated by their elevated PD-1 expression, references [22,23]. The gene discussed is CD8A; the disease is neoplasm.